Ullmann Wealth Partners Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$217K Buy
599
+7
+1% +$2.4K 0.02% 167
2026
Q1
$208K Buy
+592
New +$211K 0.02% 152

Other funds holding AMGN

Ullmann Wealth Partners Group's AMGN Position: Q2 2026 in Review

Ullmann Wealth Partners Group increased its Amgen (AMGN) stake by 1.2% in Q2 2026, buying an estimated $2.4K and bringing the position to 599 shares worth $217K. The position accounts for 0.02% of the portfolio, ranked #167.

Ullmann Wealth Partners Group first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ullmann Wealth Partners Group held 599 shares of Amgen worth $217K as of Q2 2026.
  • Ullmann Wealth Partners Group bought 7 Amgen shares in Q2 2026, an estimated $2.4K.
  • Amgen made up 0.02% of Ullmann Wealth Partners Group's portfolio in Q2 2026, its #167 holding.
  • Ullmann Wealth Partners Group first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
  • 3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ullmann Wealth Partners Group's 13F filing for Q2 2026, filed 10 Aug 2026.